Insider · CIK 0002135139

Hinsch Gylvin Lykke

Reports to the SEC for 1 company · LEIDEN

Transactions

Companies

Filings

CIK

0002135139

Forms 4 and 5

Insider transactions

2 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-02	PRQRProQR Therapeutics N.V. · Share Option (Right to Buy)A Award	Director	AAward	+14.5K sh	—	—	14,495
2026-06-02	PRQRProQR Therapeutics N.V. · Share Option (Right to Buy)A Award	Director	AAward	+14.6K sh	—	—	14,595

PROQR THERAPEUTICS N.V. ZERNIKEDREEF 9

LEIDEN, 2333 CK